Naser Jwan A, Harada Tomonari, Reddy Yogesh N, Pislaru Sorin V, Michelena Hector I, Scott Christopher G, Kennedy Austin M, Pellikka Patricia A, Nkomo Vuyisile T, Eleid Mackram F, Borlaug Barry A
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Department of Quantitative Health Sciences and Biostatistics, Mayo Clinic, Rochester, Minnesota.
JAMA Cardiol. 2025 Feb 1;10(2):182-187. doi: 10.1001/jamacardio.2024.3767.
Secondary tricuspid regurgitation (STR) is observed in multiple cardiac and pulmonary diseases. Heart failure with preserved ejection fraction (HFpEF) is a common cause of STR that may be overlooked, along with precapillary etiologies of pulmonary hypertension (PH).
To investigate the prevalence of HFpEF and precapillary PH in patients with severe STR of undefined etiology (isolated STR) referred for exercise right heart catheterization (RHC), and to evaluate the performance of noninvasive measures to identify HFpEF.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cross-sectional study included consecutive adults with severe STR in the absence of EF less than 50%, hemodynamically significant left-sided valve disease, congenital heart disease, infiltrative or hypertrophic cardiomyopathy, pericardial disease, or prior cardiac procedures who underwent rest-and-exercise RHC between February 2006 and June 2023 at Mayo Clinic and transthoracic echocardiography less than 90 days prior. Diastolic dysfunction (DD) was defined by at least 3 of 4 or 2 of 3 abnormal diastolic parameters (medial e', medial E/e', tricuspid regurgitation [TR] velocity, left atrial volume index). HFpEF was diagnosed when pulmonary arterial wedge pressure was at least 15 mm Hg at rest, at least 19 mm Hg with feet up, or at least 25 mm Hg during exercise. Data analysis was performed from November 2023 to March 2024.
The prevalence of HFpEF and precapillary PH in severe isolated STR was determined, and performance of noninvasive measures to identify HFpEF was evaluated.
Overall, 54 patients with severe isolated STR (mean [SD] age, 70.8 [12.5] years; 34 [63%] female) were identified. The primary indication for RHC was evaluation of TR prior to potential intervention in 36 patients (67%), evaluation of PH in 13 (24%), and confirmation of HFpEF in 5 (9%). HFpEF was identified in 40 patients (74%) but was recognized prior to RHC in only 19 patients (35%). Of the 14 remaining patients without HFpEF, precapillary PH was diagnosed in 10 (71%). Guideline-defined DD was absent in 24 patients (60%) who were subsequently diagnosed with HFpEF. Left atrial emptying fraction (area under the receiver operating characteristic curve [AUC] = 0.90; 95% CI, 0.82-0.98) and strain (AUC = 0.91; 95% CI, 0.83-0.99) had robust discrimination for HFpEF.
The findings suggest that HFpEF is underdiagnosed and should be rigorously evaluated for in patients with severe isolated STR, along with precapillary PH, as both have distinct requirements for management. Resting DD based on current guidelines is insufficiently sensitive in these patients, indicating a pressing need for other noninvasive diagnostic tools, such as left atrial function assessment.
继发性三尖瓣反流(STR)在多种心脏和肺部疾病中均有观察到。射血分数保留的心力衰竭(HFpEF)是STR的常见病因,可能被忽视,同时还有肺动脉高压(PH)的毛细血管前病因。
调查因不明病因的严重STR(孤立性STR)而接受运动右心导管检查(RHC)的患者中HFpEF和毛细血管前PH的患病率,并评估非侵入性措施识别HFpEF的性能。
设计、设置和参与者:这项回顾性横断面研究纳入了2006年2月至2023年6月在梅奥诊所接受静息和运动RHC且在90天内进行过经胸超声心动图检查的连续成年患者,这些患者患有严重的孤立性STR,且射血分数不低于50%,无血流动力学显著意义的左侧瓣膜疾病、先天性心脏病、浸润性或肥厚性心肌病、心包疾病或既往心脏手术史。舒张功能障碍(DD)由4项舒张参数中的至少3项异常或3项中的2项异常(e'平均值、E/e'平均值、三尖瓣反流[TR]速度、左心房容积指数)定义。当静息时肺动脉楔压至少为15 mmHg、抬腿时至少为19 mmHg或运动时至少为25 mmHg时,诊断为HFpEF。数据分析于2023年11月至2024年3月进行。
确定严重孤立性STR中HFpEF和毛细血管前PH的患病率,并评估非侵入性措施识别HFpEF的性能。
总体而言,共识别出54例严重孤立性STR患者(平均[标准差]年龄为70.8 [12.5]岁;34例[63%]为女性)。RHC的主要指征是在36例患者(67%)中对潜在干预前的TR进行评估,13例(24%)中对PH进行评估,5例(9%)中对HFpEF进行确认。40例患者(74%)被诊断为HFpEF,但在RHC之前仅19例患者(35%)被识别。在其余14例无HFpEF的患者中,10例(71%)被诊断为毛细血管前PH。24例(60%)随后被诊断为HFpEF的患者不存在指南定义的DD。左心房排空分数(受试者工作特征曲线下面积[AUC] = 0.90;95%置信区间,0.82 - 0.98)和应变(AUC = 0.91;95%置信区间,0.83 - 0.99)对HFpEF具有较强的鉴别能力。
研究结果表明,HFpEF诊断不足,对于严重孤立性STR患者应进行严格评估,同时评估毛细血管前PH,因为两者在管理上有不同要求。基于当前指南的静息DD在这些患者中敏感性不足,这表明迫切需要其他非侵入性诊断工具,如左心房功能评估。